Clinical Research Directory
Browse clinical research sites, groups, and studies.
ProSight: A Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population
Sponsor: Shanghai Weihe Medical Laboratory Co., Ltd.
Summary
This is a prospective, multi-centre interventional study evaluating the feasibility of blood-based multi-cancer early detection test in asymptomatic screening cohort.
Official title: Feasibility of Blood-based Test for Multi-cancer Early Detection in Asymptomatic Screening Population(ProSight): a Multi-centre Interventional Study
Key Details
Gender
All
Age Range
40 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
2527
Start Date
2025-03-01
Completion Date
2026-08-31
Last Updated
2026-09-04
Healthy Volunteers
Yes
Interventions
multi-cancer early detection
Blood collection for multi-cancer early detection(MCED), followed by clinical diagnosis based on the results of MCED and standard-of-care screening
Locations (4)
Fujian Cancer Hospital
Fuzhou, Fujian, China
Henan Cancer Hospital
Zhengzhou, Henan, China
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China